Colorectal cancer classification with differential prognosis and personalized therapeutic responses

The present invention relates to gene sets, the expression levels of which are useful for classifying colorectal tumors and predicting disease-free prognosis and response of patients to specific therapies that are either novel or currently available in the clinics for colorectal cancer patients.


Year:
2015
Other identifiers:
EPO Family ID: 50002795
TTO: 6.1229
Laboratories:




 Record created 2017-05-24, last modified 2018-03-17


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)